V001-3043 Screening compound: 1-(cyclohexylmethyl)-2-{4-[4-(2-fluorophenyl)piperazine-1-carbonyl]piperidin-1-yl}-1H-1,3-benzodiazole

V001-3043 Screening compound: 1-(cyclohexylmethyl)-2-{4-[4-(2-fluorophenyl)piperazine-1-carbonyl]piperidin-1-yl}-1H-1,3-benzodiazole
V001-3043 Screening compound: 1-(cyclohexylmethyl)-2-{4-[4-(2-fluorophenyl)piperazine-1-carbonyl]piperidin-1-yl}-1H-1,3-benzodiazole alternative view

Chemical Structure Depiction of ChemDiv screening compound V001-3043
1-(cyclohexylmethyl)-2-{4-[4-(2-fluorophenyl)piperazine-1-carbonyl]piperidin-1-yl}-1H-1,3-benzodiazole

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V001-3043

Molecular Formula

C30H38FN5O (C30 H38 FN5 O)

Compound Name

1-(cyclohexylmethyl)-2-{4-[4-(2-fluorophenyl)piperazine-1-carbonyl]piperidin-1-yl}-1H-1,3-benzodiazole

IUPAC name

1-(cyclohexylmethyl)-2-{4-[4-(2-fluorophenyl)piperazine-1-carbonyl]piperidin-1-yl}-1H-13-benzodiazole

SMILES

O=C(C(CC1)CCN1c1nc(cccc2)c2n1CC1CCCCC1)N(CC1)CCN1c(cccc1)c1F

InChI

InChI=1S/C30H38FN5O/c31-25-10-4-6-12-27(25)33-18-20-34(21-19-33)29(37)24-14-16-35(17-15-24)30-32-26-11-5-7-13-28(26)36(30)22-23-8-2-1-3-9-23/h4-7,10-13,23-24H,1-3,8-9,14-22H2

InChI Key

TUNJSTFUHMYUEG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19968698

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

503.66

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

6.398

Distribution Coefficient, logD

6.390

Water Solubility, LogSw

-6.00

Polar Surface Area

32.960

Acid Dissociation Constant (pKa)

21.91

Base Dissociation Constant (pKb)

8.46

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

53.30

V001-3043 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V001-3043 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V001-3043?
Check Price and Availability of V001-3043, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V001-3043 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V001-3043
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V001-3043
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V001-3043 available by request